Dirie Najib Isse, Sh Nur Maryan Abdullahi, Mohamud Abdirahman Khalif, Garba Bashiru, Dahie Hassan Abdullahi, Adam Mohamed Hussein, Mohamoud Jamal Hassan
Department of Urology, Dr Sumait Hospital, Faculty of Medicine, and Health Sciences, SIMAD University, Mogadishu, Somalia.
Department of Obstetrics and Gynecology, Dr Sumait Hospital, Faculty of Medicine and Health Sciences, SIMAD University, Mogadishu, Somalia.
Infect Drug Resist. 2024 Sep 10;17:3933-3943. doi: 10.2147/IDR.S471674. eCollection 2024.
Pregnant women exhibit COVID-19 vaccine hesitancy due to concerns regarding potential risks to their babies, doubts about vaccine efficacy, and limited access to information. Therefore, this study aims to estimate COVID-19 vaccine uptake and factors associated with pregnant women in Mogadishu, Somalia.
A cross-sectional study was conducted on pregnant women using a questionnaire covering socio-demographic information, pregnancy-related characteristics, perceptions about the COVID-19 vaccine, and vaccination status. Univariable and multivariable logistic regression analyses were utilized to identify factors associated with the outcome variable.
Among the 400 pregnant women who participated in this study, 26.8% had received a COVID-19 vaccine dose, with only 14.9% receiving it during pregnancy. Reasons for not receiving the vaccine included a lack of information about the vaccine (47.4%), concerns about its adverse effects on personal health (33.8%), misconceptions regarding impacts on fertility or menstrual cycles (14.3%), belief in the vaccine's inefficacy (3.4%), and fears about adverse effects on their fetus. In multivariable logistic regression, pregnant women with a history of chronic diseases (AOR=3.27, 95% CI=1.992-6.145), those who perceived themselves at risk of contracting COVID-19 (AOR=3.81, 95% CI=2.11-5.10), those who believed that the vaccine was accessible to them (AOR=4.34, 95% CI=2.915-6.165), and those who discussed the COVID-19 vaccine with their healthcare provider (AOR=3.91, 95% CI=2.123-7.878) were more likely to receive the COVID-19 vaccine compared to their counterparts.
Pregnant women in Mogadishu, Somalia, face challenges with sub-optimal covid-19 vaccine uptake. Implementations should improve awareness of COVID-19 risks and facilitate discussions between healthcare providers and pregnant women. In addition, efforts to provide reliable information about the vaccine, alleviate concerns about its adverse effects, and dispel misconceptions about fertility, menstrual cycles, efficacy, and foetal impact are crucial.
由于担心对胎儿有潜在风险、对疫苗效力存疑以及获取信息有限，孕妇对新冠疫苗存在犹豫态度。因此，本研究旨在估计索马里摩加迪沙孕妇的新冠疫苗接种率以及与之相关的因素。
对孕妇开展了一项横断面研究，使用的问卷涵盖社会人口学信息、与妊娠相关的特征、对新冠疫苗的看法以及疫苗接种状况。采用单变量和多变量逻辑回归分析来确定与结果变量相关的因素。
在参与本研究的400名孕妇中，26.8%接种过一剂新冠疫苗，其中只有14.9%是在孕期接种的。未接种疫苗的原因包括缺乏疫苗信息（47.4%）、担心对个人健康有不良影响（33.8%）、对影响生育或月经周期存在误解（14.3%）、认为疫苗无效（3.4%）以及担心对胎儿有不良影响。在多变量逻辑回归中，有慢性病病史的孕妇（比值比=3.27，95%置信区间=1.992 - 6.145）、认为自己有感染新冠风险的孕妇（比值比=3.81，95%置信区间=2.11 - 5.10）、认为自己能够接种疫苗的孕妇（比值比=4.34，95%置信区间=2.915 - 6.165）以及与医护人员讨论过新冠疫苗的孕妇（比值比=3.91，95%置信区间=2.123 - 7.878）相比其他孕妇更有可能接种新冠疫苗。
索马里摩加迪沙的孕妇在新冠疫苗接种率未达最佳水平方面面临挑战。应采取措施提高对新冠风险的认识，并促进医护人员与孕妇之间的讨论。此外，努力提供有关疫苗的可靠信息、减轻对其不良影响的担忧以及消除对生育、月经周期、效力和胎儿影响的误解至关重要。
